| Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas NL Albert, M Weller, B Suchorska, N Galldiks, R Soffietti, MM Kim, ... Neuro-oncology 18 (9), 1199-1208, 2016 | 704 | 2016 |
| Immunotherapy response assessment in neuro-oncology: a report of the RANO working group H Okada, M Weller, R Huang, G Finocchiaro, MR Gilbert, W Wick, ... The Lancet Oncology 16 (15), e534-e542, 2015 | 677 | 2015 |
| Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials BM Ellingson, M Bendszus, J Boxerman, D Barboriak, BJ Erickson, ... Neuro-oncology 17 (9), 1188-1198, 2015 | 640 | 2015 |
| Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme A Lai, A Tran, PL Nghiemphu, WB Pope, OE Solis, M Selch, E Filka, ... Journal of clinical oncology 29 (2), 142, 2011 | 561 | 2011 |
| Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin A Lai, S Kharbanda, WB Pope, A Tran, OE Solis, F Peale, WF Forrest, ... Journal of clinical oncology 29 (34), 4482, 2011 | 524 | 2011 |
| 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy W Chen, DHS Silverman, S Delaloye, J Czernin, N Kamdar, W Pope, ... Journal of Nuclear Medicine 47 (6), 904-911, 2006 | 516 | 2006 |
| Predicting Treatment Response of Malignant Gliomas to Bevacizumab and Irinotecan by Imaging Proliferation With (18F Fluorothymidine Positron Emission Tomography: A Pilot Study W Chen, S Delaloye, DHS Silverman, C Geist, J Czernin, J Sayre, ... Journal of Clinical Oncology 25 (30), 4714-4721, 2007 | 489 | 2007 |
| MR imaging correlates of survival in patients with high-grade gliomas WB Pope, J Sayre, A Perlina, JP Villablanca, PS Mischel, TF Cloughesy American Journal of Neuroradiology 26 (10), 2466-2474, 2005 | 486 | 2005 |
| Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy WB Pope, RM Prins, M Albert Thomas, R Nagarajan, KE Yen, MA Bittinger, ... Journal of neuro-oncology 107, 197-205, 2012 | 372 | 2012 |
| MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy WB Pope, A Lai, P Nghiemphu, P Mischel, TF Cloughesy Neurology 66 (8), 1258-1260, 2006 | 361 | 2006 |
| Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment1 WB Pope, HJ Kim, J Huo, J Alger, MS Brown, D Gjertson, V Sai, JR Young, ... Radiology 252 (1), 182-189, 2009 | 355 | 2009 |
| Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma JA Carrillo, A Lai, PL Nghiemphu, HJ Kim, HS Phillips, S Kharbanda, ... American Journal of Neuroradiology 33 (7), 1349-1355, 2012 | 308 | 2012 |
| Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience PL Nghiemphu, W Liu, Y Lee, T Than, C Graham, A Lai, RM Green, ... Neurology 72 (14), 1217-1222, 2009 | 281 | 2009 |
| Multi-delay multi-parametric arterial spin-labeled perfusion MRI in acute ischemic stroke—comparison with dynamic susceptibility contrast enhanced perfusion imaging DJJ Wang, JR Alger, JX Qiao, M Gunther, WB Pope, JL Saver, N Salamon, ... NeuroImage: Clinical 3, 1-7, 2013 | 234 | 2013 |
| The value of arterial spin-labeled perfusion imaging in acute ischemic stroke: comparison with dynamic susceptibility contrast-enhanced MRI DJJ Wang, JR Alger, JX Qiao, Q Hao, S Hou, R Fiaz, M Gunther, WB Pope, ... Stroke 43 (4), 1018-1024, 2012 | 228 | 2012 |
| Pseudoprogression, radionecrosis, inflammation or true tumor progression? Challenges associated with glioblastoma response assessment in an evolving therapeutic landscape BM Ellingson, C Chung, WB Pope, JL Boxerman, TJ Kaufmann Journal of neuro-oncology 134, 495-504, 2017 | 219 | 2017 |
| Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma WB Pope, A Lai, R Mehta, HJ Kim, J Qiao, JR Young, X Xue, J Goldin, ... American Journal of Neuroradiology 32 (5), 882-889, 2011 | 217 | 2011 |
| Probabilistic radiographic atlas of glioblastoma phenotypes BM Ellingson, A Lai, RJ Harris, JM Selfridge, WH Yong, K Das, WB Pope, ... American Journal of neuroradiology 34 (3), 533-540, 2013 | 211 | 2013 |
| Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma … A Lai, E Filka, B McGibbon, PL Nghiemphu, C Graham, WH Yong, ... International Journal of Radiation Oncology* Biology* Physics 71 (5), 1372-1380, 2008 | 208 | 2008 |
| Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide W Wick, P Roth, C Hartmann, P Hau, M Nakamura, F Stockhammer, ... Neuro-oncology 18 (11), 1529-1537, 2016 | 200 | 2016 |
Timothy CloughesyUCLAVerified email at mednet.ucla.edu
